Bellerophon Therapeutics Inc logo

Bellerophon Therapeutics Inc

FRA:6L7A (USA)  
€ 0.35 (0%) Oct 24
At Loss
Market Cap:
€ 631.00K ($ 693.00K)
Enterprise V:
€ -13.58M ($ -14.91M)
Volume:
-
Avg Vol (2M):
-
Trade In:

Business Description

Description
Bellerophon Therapeutics Inc is a clinical-stage therapeutics company. The firm develops innovative products combining novel drugs and devices to treat cardiopulmonary diseases. It develops products under its INOpulse platform, which is an extension of the technology that is used in hospitals to deliver continuous-flow inhaled nitric oxide. The company's products are aimed at the treatment of different kinds of pulmonary hypertension.
Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 56.34
9-Day RSI 60.61
6-1 Month Momentum % -96.05
12-1 Month Momentum % -65.38

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History
FCF Margin % -218.93

GF Value Rank

Name Current Vs Industry Vs History
EV-to-Forward-Revenue 6.19

Financials (Next Earnings Date:2024-10-08 Est.)

FRA:6L7A's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Bellerophon Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 5.268
EPS (TTM) (€) -0.636
Beta 0
Volatility % 496.59
14-Day RSI 0
14-Day ATR (€) 0.038429
20-Day SMA (€) 0
12-1 Month Momentum % -65.38
52-Week Range (€) 0.322 - 11.15
Shares Outstanding (Mil) 12.23

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Bellerophon Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Bellerophon Therapeutics Inc Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Bellerophon Therapeutics Inc Frequently Asked Questions

What is Bellerophon Therapeutics Inc(FRA:6L7A)'s stock price today?
The current price of FRA:6L7A is €0.35. The 52 week high of FRA:6L7A is €11.15 and 52 week low is €0.32.
When is next earnings date of Bellerophon Therapeutics Inc(FRA:6L7A)?
The next earnings date of Bellerophon Therapeutics Inc(FRA:6L7A) is 2024-10-08 Est..
Does Bellerophon Therapeutics Inc(FRA:6L7A) pay dividends? If so, how much?
Bellerophon Therapeutics Inc(FRA:6L7A) does not pay dividend.

Press Release

Subject Date
No Press Release